Don't want ads? Subscribe or login now.

Genentech Dodges FCA Claims Over Avastin's Side Effects

By Daniel Langhorne · October 29, 2015, 11:55 PM EDT

A New Jersey federal judge on Thursday dismissed a False Claims Act against Genentech Inc. regarding its cancer drug Avastin, holding a whistleblower didn't show the drug's advertised claims were false...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

PETRATOS et al v. GENENTECH, INC. et al

Case Number

2:11-cv-03691

Court

New Jersey

Nature of Suit

Other Statutory Actions

Date Filed

June 27, 2011

Recent Articles By Daniel

November 04, 2015
Ky. Clerk Slams Judge's Contempt Order At 6th Circ.
November 04, 2015
Kraft Agrees To $1.75M Deal To End Unpaid Wages Row
November 02, 2015
Holland & Knight Settles Recruiter's Suit Over Placement Fees
October 30, 2015
NLRB Upholds Bar Of Teamster's JFK Worker Representation
October 29, 2015
Ariz. Judge Slams Attys' Dispute In FCA Row As 'The Worst'
October 28, 2015
Sutter Health Loses Appeal To Arbitrate Antitrust Row
October 27, 2015
Bankrupt Molycorp Proposes $2.5M Bonus Cap For Execs
October 26, 2015
FedEx Cleared By Jury In Disability Bias Trial
October 21, 2015
Ex-Federal Prosecutor Files Sex Bias Suit Against DOJ
October 19, 2015
Calif. Court Revives Cert. Bid For Nurses In Meal, OT Action